Skip to content
TrialScanner

NCT05124795

IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer

Phase 1TerminatedIMUXLead

Registry record

Lead sponsor
Immunic AG
Conditions
Metastatic Castration Resistant Prostate Cancer
Primary completion
May 31, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05124795 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05124795: IMU-935 in Patients With... | TrialScanner